Popular Articles

MeritTrac plans to invest Rs 20-cr to up offerings
When the IIMs decided to award the contract to Prometric for conducting the Common Admission Test (CAT) online, and Pearson bringing its assessment brand to India, it must have been a wake up call for MeritTrac, a large assessment company. But, the company is not losing sleep.

Indian ADRs lose $4 bn in a week
Indian stocks trading on American bourses lost $3.85 billion (around Rs 18,000 crore) from their total market valuation last week, with HDFC Bank and Sterlite Industries leading the pack.

News of the day

Sugar stocks sweeten on hopes of robust growth
Balrampur Chini ended flat at Rs 133, Around 410,679 shares were traded as compared to the two-week daily average traded volumes of 1.04 million shares.
Management

Give tax sops on exports of medical textiles: FICCI

The government should cover the entire chain of manufacturing medical textile for exports under tax benefits for promoting a promising area of growth in the global market, industry body FICCI said. - Moving on 3G - India"s IT boom a brainchild of Indira Gandhi: New book - PM to chair Inter-State Trade Council meet next month - Kharif crop output to fall 15-20%: FM - Spice exports decline 14% in April-July - FTP good blueprint to arrest declining exports: Industry "...There is a large untapped potential in exports of these new generation non-woven (man-made fibres) medical textiles, especially to developed countries like the US" FICCI said in a statement here. To tap this market (the US and EU), the industry would require export incentives like Duty Entitlement Pass Book Scheme (DEPB) to be competitive in global markets, it said. Under the DEPB scheme, companies can avail refund of customs duty paid on imported raw material for manufacturing products meant to be exported.Medical textile products include gowns, caps, masks, drapes, hospital uniforms, bandages, surgical dressings and hospital beddings. "Currently, DEPB rates are provided for only those medical textiles which are manufactured from spun yarn, and non-woven fabrics (directly made from the fibres)do not get any DEPB benefit," it said. The current medical textiles market in India is around Rs 2,365 crore and is expected to touch Rs 3,737 crore by 2012-13, it added. "This offers a huge opportunity for new generation medical textiles in India", it said. It further said that the government should amend Indian Drugs and Cosmetics Act to include new generation medical textiles made of fibres and disposable medical textile products. These fibres are now extensively used in foreign countries for various medical textile products. "Medical textiles made of cotton as used currently in the country do not meet many of the health and safety requirements," it said. Most of the hospitals in India continue to use these traditional products despite being less hygienic, since the new and latest products are not included under the Drugs and Cosmetic Act of India, FICCI Taskforce on Technical Textiles Chairman Shishir Jaipuria said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):